Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 3 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

0
Player Avatar subsurfacemapper (69.79) Submitted: 11/17/2010 12:39:34 AM : Outperform Start Price: $13.56 QCOR Score: +194.30

Inside ownership over 10%, no debt, ROE of 39, long term growth est 31%. Screen result.

Report this Post 1 Comment
Member Avatar subsurfacemapper (69.79) Submitted: 4/15/2011 1:03:41 AM
Recs: 0

I just ran the same screen now in April 2011 and QCOR is still there, while I am up with a CAP of 30 points on this one. I should leave it in the picked basket.

Featured Broker Partners


Advertisement